Skip to main content

Table 2 Patient numbers evaluated as being the glucose intolerant type of diabetes mellitus [n (%)]

From: The influence of a long-term growth hormone treatment on lipid and glucose metabolism: a randomized trial in short Japanese children born small for gestational age

 

0.033 mg/kg/day

0.067 mg/kg/day

Total

Glucose intolerant type

Time point evaluated as the glucose intolerant type

Total

Glucose intolerant type

Time point evaluated as the glucose intolerant type

Before

60 mina

120 min

Before

60 min*

120 min

Baseline

31 (100 %)

3 (9.7 %)

1 (3.2 %)

0 (0.0 %)

2 (6.5 %)

34 (100 %)

1 (2.9 %)

0 (0.0 %)

0 (0.0 %)

1 (2.9 %)

52 weeks

29 (100 %)

3 (10.3 %)

0 (0.0 %)

2 (6.9 %)

1 (3.4 %)

34 (100 %)

3 (8.8 %)

0 (0.0 %)

3 (8.8 %)

0 (0.0 %)

104 weeks

29 (100 %)

2 (6.9 %)

0 (0.0 %)

0 (0.0 %)

2 (6.9 %)

32 (100 %)

2 (6.3 %)

0 (0.0 %)

0 (0.0 %)

2 (6.3 %)

156 weeks

25 (100 %)

1 (4.0 %)

0 (0.0 %)

0 (0.0 %)

1 (4.0 %)

29 (100 %)

2 (6.9 %)

0 (0.0 %)

0 (0.0 %)

2 (6.9 %)

208 weeks

25 (100 %)

0 (0.0 %)

0 (0.0 %)

0 (0.0 %)

0 (0.0 %)

28 (100 %)

3 (10.7 %)

0 (0.0 %)

2 (7.1 %)

1 (3.6 %)

260 weeks

23 (100 %)

1 (4.3 %)

1 (4.3 %)

0 (0.0 %)

0 (0.0 %)

27 (100 %)

4 (14.8 %)

0 (0.0 %)

1 (3.7 %)

3 (11.1 %)

  1. aPatients with a blood glucose level of 180 mg/dL or more 60 min after OGTT were regarded as being glucose intolerant [14]. OGTT, oral glucose tolerance test